Diethyl Hydrogen Phosphate

Diethyl Hydrogen Phosphate

SCHEMBL376684

CC(=O)O.CCOP(=O)(O)OCC

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Diethyl Hydrogen Phosphate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.46
PPARD Q03181 2/20 0.44
TP53 P04637 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
HSD17B10 Q99714 1/20 0.38
FFAR3 O14843 1/20 0.37
LCK P06239 1/20 0.37
FYN P06241 1/20 0.37
MVD P53602 1/20 0.36
POLB P06746 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethyl Hydrogen Phosphate SCHEMBL28596733 0.97 TSHR (0.43) TSHRPPARDTP53TDP1CA12
Diethyl Hydrogen Phosphate SCHEMBL31065172 0.92 TSHR (0.48) TSHRPPARDTP53TDP1CA12
Acetic Acid SCHEMBL28479624 0.89 PPARD (0.38) TSHRPPARDCA12CA1CA2
Diethyl Hydrogen Phosphate SCHEMBL27873282 0.89 PPARD (0.38) TSHRPPARDTP53TDP1CA12
Diethyl Hydrogen Phosphate SCHEMBL27294237 0.89 TSHR (0.56) TSHRPPARDTP53TDP1CA12
Diethyl Hydrogen Phosphate SCHEMBL93056 0.89
Diethyl Hydrogen Phosphate SCHEMBL27873286 0.87 TSHR (0.43) TSHRPPARDTP53TDP1CA12
Diethyl Hydrogen Phosphate SCHEMBL697968 0.86 PPARD (0.39) TSHRPPARDTP53TDP1CA12
Diethyl Hydrogen Phosphate SCHEMBL906759 0.86 TSHR (0.53) TSHRPPARDTP53TDP1CA12
Diethyl Hydrogen Phosphate SCHEMBL8431810 0.86 TSHR (0.53) TSHRPPARDTP53TDP1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122025690-A Composite modified material of high-toughness graphite bipolar plate and preparation method thereof 青岛高等密封制品有限公司 2026-05-12 CN disclosed
WO-2022088573-A1 METHOD FOR PREPARING PYROTINIB 苏州富士莱医药股份有限公司 2022-05-05 WO disclosed
CN-112358467-B Preparation process of pyrroltinib 苏州富士莱医药股份有限公司 2021-07-30 CN disclosed
CN-112279838-B Preparation method of pyrroltinib 苏州富士莱医药股份有限公司 2021-07-13 CN disclosed
CN-112358467-A Preparation process of pyrroltinib 苏州富士莱医药股份有限公司 2021-02-12 CN disclosed
CN-112279838-A Preparation method of pyrroltinib 苏州富士莱医药股份有限公司 2021-01-29 CN disclosed
CN-105884831-A Preparation method of phorate pesticide hapten and application of phorate pesticide hapten 江苏师范大学 2016-08-24 CN disclosed
CN-102448458-B Methods and compositions for treating flaviviridae virus infections UNIV LELAND STANFORD JUNIOR 2015-07-22 CN disclosed
US-8975247-B2 Methods and compositions of treating a flaviviridae family viral infection THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNION UNIVERSITY (US) 2015-03-10 US disclosed
EP-2699096-A2 METHOD FOR MOSQUITO CONTROL Dobson, Stephen (US) 2014-02-26 EP disclosed
US-20120276050-A1 METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-11-01 US disclosed
WO-2012145145-A2 METHOD FOR MOSQUITO CONTROL DOBSON STEPHEN (US) 2012-10-26 WO disclosed
CN-102448458-A Methods and compositions for treating flaviviridae virus infections UNIV LELAND STANFORD JUNIOR 2012-05-09 CN disclosed
EP-2408449-A2 METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION The Board Of Trustees Of The University Of the Leland Stanford Junior University (US) 2012-01-25 EP disclosed
WO-2010107739-A2 METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2010-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120276050-A1 METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION NSUN3, RNGTT, NSUN2 TSHR 4438/4885PPARD 2491/4885TP53 4482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.